Aydogan Bulent, Mundt Arno J, Smith Brett D, Mell Loren K, Wang Steve, Sutton Harold, Roeske John C
Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):266-73. doi: 10.1016/j.ijrobp.2005.12.049.
To evaluate the role of intensity-modulated radiation treatment (IMRT) as an alternative to high-dose-rate (HDR) brachytherapy in the treatment of the vagina in postoperative early endometrial cancer patients after surgery.
Planning computed tomography (CT) scans of 10 patients previously treated with HDR were used in this study. In all cases, a dose of 700 cGy/fraction was prescribed at a distance of 0.5 cm from the cylinder surface. The same CT scans were then used in IMRT planning. In this paradigm, the vaginal cylinder represents a component of a hypothetical immobilization system that would be indexed to the linac treatment table.
Our study showed that IMRT provided relatively lower rectal doses than HDR when treatment was prescribed at a distance of 0.5 cm away from the cylinder surface. Maximum rectal doses were lower with IMRT compared with HDR (average: 89.0% vs. 142.6%, respectively, p < 0.05). Moreover, the mean rectal dose was lower in IMRT plans compared with HDR plans with treatment prescribed either to the surface (average: 14.8% vs. 21.4%, respectively, p < 0.05) or to 0.5 cm (average: 19.6% vs. 33.5%, respectively, p < 0.05). IMRT plans had planning target volume (PTV) coverage comparable with HDR (average PTV minimum for treatment prescribed to 0.5 cm: 93.9% vs. 92.1%, p = 0.71, respectively) with less inhomogeneity (average PTV maximum: 110.8% vs. 381.6%, p < 0.05).
Our dosimetric analysis suggests that when used in conjunction with a suitable immobilization system, IMRT may provide an alternative to HDR brachytherapy in women with early endometrial cancer after hysterectomy. However, more studies are needed to evaluate the clinical merit of the IMRT in these patients.
评估调强放射治疗(IMRT)作为高剂量率(HDR)近距离放射治疗的替代方法,用于术后早期子宫内膜癌患者阴道治疗的作用。
本研究使用了10例先前接受HDR治疗患者的计划计算机断层扫描(CT)图像。在所有病例中,规定在距柱状体表面0.5 cm处给予700 cGy/分次的剂量。然后将相同的CT图像用于IMRT计划。在此模式下,阴道柱状体代表一个假设的固定系统的组成部分,该系统将与直线加速器治疗床进行匹配。
我们的研究表明,当在距柱状体表面0.5 cm处规定治疗时,IMRT提供的直肠剂量比HDR相对更低。与HDR相比,IMRT的最大直肠剂量更低(平均分别为89.0%和142.6%,p < 0.05)。此外,与HDR计划相比,IMRT计划的平均直肠剂量更低,无论是规定治疗到表面(平均分别为14.8%和21.4%,p < 0.05)还是到0.5 cm处(平均分别为19.6%和33.5%,p < 0.05)。IMRT计划的计划靶体积(PTV)覆盖率与HDR相当(规定治疗到0.5 cm处时,平均PTV最小值:分别为93.9%和92.1%,p = 0.71),且不均匀性更小(平均PTV最大值:分别为110.8%和381.6%,p < 0.05)。
我们的剂量学分析表明,当与合适的固定系统联合使用时,IMRT可能为子宫切除术后早期子宫内膜癌女性患者提供一种替代HDR近距离放射治疗的方法。然而,需要更多研究来评估IMRT在这些患者中的临床价值。